Table 2 Clinicopathological parameters of patients in prior endoscopic resection group according to the presence of LNM.

From: Comparative microRNA signatures based on liquid biopsy to identify lymph node metastasis in T1 colorectal cancer patients undergoing upfront surgery or endoscopic resection

Variable

LNM positive (n = 16)

LNM negative (n = 100)

p-value

Demographic data

 Age, years

64 (51–83)

67 (39–87)

0.95

 Sex, male

9 (56%)

52 (52%)

0.75

Tumor location

  

0.97

 Cecum

0 (0%)

3 (3%)

 

 Ascending colon

3 (19%)

16 (16%)

 

 Transverse colon

2 (13%)

12 (12%)

 

 Descending colon

0 (0%)

2 (2%)

 

 Sigmoid colon

5 (31%)

25 (25%)

 

 Rectum

6 (38%)

42 (42%)

 

Tumor size, mm

15 (6–45)

13 (3–45)

0.55

Tumor type

  

0.62

 Polypoid

11 (69%)

65 (65%)

 

 Flat

4 (25%)

19 (19%)

 

 Depressed

1 (6%)

16 (16%)

 

Tumor histology

  

0.48

 Well

6 (38%)

37 (37%)

 

 Moderate

3 (19%)

12 (12%)

 

 Poor

7 (44%)

51 (51%)

 

Tumor depth (µm)

  

0.37

 <1000

1 (6%)

11 (11%)

 

 1000–1999

3 (19%)

21 (21%)

 

 ≥2000

9 (56%)

62 (62%)

 

 Unavailable

3 (19%)

6 (6%)

 

Lymphatic invasion

  

0.90

 Positive

7 (44%)

42 (42%)

 

 Negative

9 (56%)

58 (58%)

 

Vascular invasion

  

0.027

 Positive

8 (50%)

32 (32%)

 

 Negative

7 (44%)

68 (68%)

 

 Unavailable

1 (6%)

0 (0%)

 

Tumor budding

  

0.004

 Grade 1

8 (50%)

72 (72%)

 

 Grade 2

0 (0%)

14 (14%)

 

 Grade 3

4 (25%)

4 (4%)

 

 Unavailable

4 (25%)

10 (10%)

 
  1. Values are presented as the number of patients (%) or the median (range).